Award recordCONTRACT

CSL BEHRING L.L.C.

PIID 36C26019F0383· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2019· $301,097 net obligations· UEI H3WKVE9VBLY3· PA

Description

PRIVIGEN BUNDLED MEDICATION

First action · last action
2019-05-22 · 2020-01-27
Transactions
4
First transaction's obligation
$98,479
Base + all options value (sum of deltas)
$301,097
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D50358
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 4 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$368,637$0Base award · 2019-05-22 · this action $98,479 · running total $98,479Modification P00001 · 2019-06-14 · this action $135,079 · running total $233,558Modification P00002 · 2019-08-14 · this action $135,079 · running total $368,637Modification P00003 · 2020-01-27 · this action -$67,539 · running total $301,097
  • Base2019-05-22+$98,479= $98,479
  • Mod P000012019-06-14+$135,079= $233,558
  • Mod P000022019-08-14+$135,079= $368,637
  • Mod P000032020-01-27-$67,539= $301,097
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2019-05-22+$98,479$98,479PRIVIGEN BUNDLED MEDICATION
Mod P00001· OTHER ADMINISTRATIVE ACTION2019-06-14+$135,079$233,558PRIVIGEN BUNDLED MEDICATION
Mod P00002· OTHER ADMINISTRATIVE ACTION2019-08-14+$135,079$368,637PRIVIGEN BUNDLED MEDICATION
Mod P00003· OTHER ADMINISTRATIVE ACTION2020-01-27−$67,539$301,097PRIVIGEN BUNDLED MEDICATION

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI H3WKVE9VBLY3)

AwardOffice · PSC / listingNet obligationsFY
36C24826F0207248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$183,903FY2026
36C24826F0187248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$36,781FY2026
36C25226F0318252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$85,484FY2026
36C24826F0091248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$147,122FY2026
36C24826F0037248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$124,240FY2026
36C24824F0327248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$391,583FY2024

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26019F0383_3600_V797D50358_3600 · retrieved 2026-09-26.